Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05317390 · ClinicalTrials.gov registry record · NA

Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia

A NA study of Parkinson Disease and Essential Tremor, sponsored by Massachusetts Eye and Ear Infirmary.

Recruiting
Registry status
NA
Development phase
1,000
Enrollment target
1
Study location

NCT05317390 is a NA study of Parkinson Disease and Essential Tremor that is actively recruiting participants, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 1,000 participants, below the 5,323-participant average among 297 other Parkinson Disease trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05317390, a NA study of Parkinson Disease and Essential Tremor, is actively recruiting participants, sponsored by Massachusetts Eye and Ear Infirmary.

RECRUITING
Registry status
NA
Development phase
1,000 participants
Enrollment target
1
Study location

Study Summary

This research involves retrospective and prospective studies for clinical validation of a DystoniaNet deep learning platform for the diagnosis of isolated dystonia.

Interventions

  • DIAGNOSTIC_TEST DystoniaNet-based diagnosis of isolated dystonia

Study Locations (1)

Massachusetts

  • Massachusetts Eye and Ear Infirmary - Boston

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2022-06-01
Est. Completion 2028-04-30
Phase NA

What the Registry Record Tells You About NCT05317390

The ClinicalTrials.gov registry entry for NCT05317390 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,323-participant average among 297 other Parkinson Disease trials with a reported enrollment target (81% lower). The listed sponsor is Massachusetts Eye and Ear Infirmary, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which DystoniaNet-based diagnosis of isolated dystonia is the first listed.

NCT05317390 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05317390 about?

NCT05317390 is a clinical study titled "Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia". This research involves retrospective and prospective studies for clinical validation of a DystoniaNet deep learning platform for the diagnosis of isolated dystonia.

What is the current status of trial NCT05317390?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2022-06-01. Estimated completion is 2028-04-30.

What conditions does trial NCT05317390 study?

This clinical trial studies the following conditions: Parkinson Disease, Essential Tremor, Dystonia, Tic Disorders, Dyskinesias.

What interventions are being tested in trial NCT05317390?

The interventions under investigation include: DystoniaNet-based diagnosis of isolated dystonia (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05317390?

This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05317390 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.